Travere Therapeutics to Present at Upcoming Investor Conferences
26 Février 2024 - 10:30PM
Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that
Company management will participate in the following upcoming
investor conferences in March:
Cowen 44th
Annual Health Care ConferenceMonday, March 4,
2024, at 9:10 a.m. ET
Leerink Partners Global Biopharma
ConferenceMonday, March 11, 2024, at 1:20 p.m. ET
Barclays 26th
Annual Global Healthcare ConferenceTuesday, March
12, 2024, at 2:05 p.m. ET
Live webcasts of the presentations will be
accessible on the Investor page of Travere’s website at
ir.travere.com/events-presentations. Replays will be available for
up to 30 days following each event.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for
life. We are a biopharmaceutical company that comes together every
day to help patients, families and caregivers of all backgrounds as
they navigate life with a rare disease. On this path, we know the
need for treatment options is urgent – that is why our global team
works with the rare disease community to identify, develop and
deliver life-changing therapies. In pursuit of this mission, we
continuously seek to understand the diverse perspectives of rare
patients and to courageously forge new paths to make a difference
in their lives and provide hope – today and tomorrow. For more
information, visit travere.com.
Contact Info
Media:888-969-7879mediarelations@travere.com |
Investors:888-969-7879IR@travere.com |
Travere Therapeutics (NASDAQ:TVTX)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Travere Therapeutics (NASDAQ:TVTX)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024